Device Wound Closure

Dermabond Prineo

Payments companies reported to CMS as associated with Dermabond Prineo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)

3,546clinicians with associated payments

5companies reporting

By year

2023 $523K

2024 $478K

2025 $328K

Payments reported as associated with Dermabond Prineo, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Adult Reconstructive Orthopaedic Surgery $402K

Surgical $268K

Physician Assistant $121K

Obstetrics & Gynecology $94K

Orthopaedic Surgery of The Spine $88K

Nurse Practitioner $73K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dermabond Prineo

These are the largest totals companies reported as associated with Dermabond Prineo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Michael Mont	Baltimore, MD	Adult Reconstructive Orthopaedic Surgery	$223,176.56
Jeanine Gargiulo	Alexandria, VA	Surgical	$100,146.10
Michael Berke	Atlanta, GA	Surgical	$87,534.47
Antonia Chen	Dallas, TX	Adult Reconstructive Orthopaedic Surgery	$83,155.21
Alissa Helvik	Coeur D Alene, ID	Nurse Practitioner	$68,765.78
Ryan Nunley	Saint Louis, MO	Adult Reconstructive Orthopaedic Surgery	$65,853.13
Steven Mccarus	Celebration, FL	Obstetrics & Gynecology	$54,806.45
Gerald Buchert	Bellaire, TX	Surgical	$54,226.52
Eric Klineberg	Sacramento, CA	Orthopaedic Surgery of The Spine	$53,942.32
Seth King	Bowling Green, KY	Physician Assistant	$46,502.93

Prescribed Dermabond Prineo?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.